编者按:2020年AACR大会下半场于当地时间6月22~24日在线上举行。肾细胞癌(RCC)肿瘤浸润性免疫细胞PD-L1表达与预后的关系已有报道。本次AACR大会上,Hirotsugu U.等报道了..
作者:肿瘤瞭望 有19356人浏览 发布于:2020-06-26
编者按:2020年ASCO会议已落下帷幕,但追寻更好的治疗策略的脚步却从未停止。我国胃癌年新发病例约50万,占全球新发病例的一半,是名副其实的胃癌大国。随着近年精准治疗的..
作者:肿瘤瞭望 有23289人浏览 发布于:2020-06-26
导读:对于70岁以上的低危早期乳腺癌患者来说,保乳术后是否要进行放疗或内分泌治疗?近期《Breast Cancer Research and Treatment》上发表了一篇题目为《Radiation and/or..
作者:肿瘤瞭望 有15833人浏览 发布于:2020-06-26
编者按:随着全球生物制剂市场份额的增加及各种生物制剂专利逐渐到期,生物类似药蜂拥而至。但国内的生物类似药较少,尚处于早期阶段。基于此现状,我们不禁要画个问号,生..
作者:肿瘤瞭望 有14499人浏览 发布于:2020-06-26
导读:HER2+早期乳腺癌是一种异质性疾病,包含所有乳腺癌本质亚型。目前唯一可用于抗HER2治疗选择的生物标志物是HER2状态本身,但雌激素受体(estrogen receptor,ER)状态..
作者:肿瘤瞭望 有19339人浏览 发布于:2020-06-25
In this interview, Dr. Peng Ling from the First Affiliated Hospital,School of Medicine, Zhejiang University, Dr. Mei Heng from the Union Hospital, Tongji M..
作者:肿瘤瞭望 有17007人浏览 发布于:2020-06-23
In this interview, Professor Xu Yingying from the First Affiliated Hospital of China Medical University will talk with Professor Javier Cortes from IOB, Insti..
作者:肿瘤瞭望 有16392人浏览 发布于:2020-06-23
Editor’s note: The annual meeting of American Society of Clinical Oncology (ASCO) was held in the form of online conference for the first time, the theme of ..
作者:肿瘤瞭望 有24176人浏览 发布于:2020-06-23
At the 2020 ASCO conference, Professor Thomas Powles from Barts Cancer Institute and the London School of Medicine and Dentistry, UK, has reported the JAVELI..
作者:肿瘤瞭望 有13977人浏览 发布于:2020-06-23
Editor’s note: May 29th, 2020 to 2nd June 2020, the annual meeting of the American Society of Clinical Oncology (ASCO) was held as a virtual meeting online ..
作者:肿瘤瞭望 有26870人浏览 发布于:2020-06-23
邵志敏教授:国研双表位ADC TQB2102新辅..
SIBCS 2025丨闫敏、王浩、赵亚新教授分享..
ILCA 2025丨高强教授:KRAS突变肝内胆管..
乳事大咖说丨邵彬教授与徐菲、李俏、赵伟..